What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 5 minute read Pharma Industry News LOTTE BIOLOGICS secures third major contract of 2025 through new U.S. biopharma manufacturing deal LOTTE BIOLOGICS wins a third U.S. contract in 2025, boosting its CDMO momentum and investor sentiment. Find out how the deal shapes biomanufacturing strategy. bySoujanya RaviSeptember 2, 2025